A randomized phase III study of duration of anti-PD-1 therapy in metastatic melanoma (STOP-GAP): Canadian Clinical Trials Group study (CCTG) ME.13. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Baetz, Tara D
  • Song, Xinni
  • Ernst, D Scott
  • McWhirter, Elaine
  • Petrella, Teresa M
  • Savage, Kerry J
  • Smylie, Michael
  • Wong, Ralph
  • Lee, Christopher W
  • Look Hong, Nicole
  • Logan, Diane
  • Raza, Muhammed Saleem
  • Abbas, Tahir
  • Nomikos, Dora
  • Leung, Roger
  • Chen, Bingshu E
  • Dancey, Janet

publication date

  • May 20, 2018